Triflunordazepam
Clinical data | |
---|---|
ATC code | none |
Identifiers | |
| |
CAS Number | 2285-16-7 Y |
PubChem (CID) | 16795 |
Chemical and physical data | |
Formula | C16H11F3N2O |
Molar mass | 304.267 g/mol |
3D model (Jmol) | Interactive image |
| |
(verify) |
Triflunordazepam (also known as Ro5-2904)[1] is a drug which is a benzodiazepine derivative with high GABAA receptor affinity, and has anticonvulsant effects.[2][3]
See also
References
- ↑ DE Patent 1136709
- ↑ Archives Internationales de Pharmacodynamie et de Thérapie. (1965). Vol 154, p 131.
- ↑ So SS, Karplus M (December 1996). "Genetic neural networks for quantitative structure-activity relationships: improvements and application of benzodiazepine affinity for benzodiazepine/GABAA receptors". Journal of Medicinal Chemistry. 39 (26): 5246–56. doi:10.1021/jm960536o. PMID 8978853.
This article is issued from Wikipedia - version of the 2/27/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.